Last reviewed · How we verify
NCT05971420: MCI
Virtual Reality Activity-based Training for Preventing Falls for Older Adults With Mild Cognitive Impairment
NA trial testing VR activity-based in Mild Cognitive Impairment in 18 participants. Completed in 15 January 2022.
30 December 2021
Quick facts
| Lead sponsor | University of Southern Queensland |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | health services research |
| Enrollment | 18 |
| Start date | 1 July 2021 |
| Primary completion | 30 December 2021 |
| Estimated completion | 15 January 2022 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- VR activity-based
- Exercise-based (Baduanjin)
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
- Fall Prevention — all drugs for Fall Prevention →
- Virtual Reality — all drugs for Virtual Reality →
- Exercise Training — all drugs for Exercise Training →
Sponsor
University of Southern Queensland
Who can join
Adults 65 to 85, any sex, with Mild Cognitive Impairment or Fall Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Using a Virtual Reality (VR) games-based application is as an innovative falls prevention technology in an aged care service. The VR intervention has promising effects on improving the physical and balance performances in the older adults.The study explored and evaluated the effects of VR activity-based training on falls prevention among community-dwelling older adults with mild cognitive impairment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05971420
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05971420 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern Queensland
- Last refreshed: 2 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05971420.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing